The Hims & Hers Multi-Cancer Test by Galleri® looks for a shared signal of 50+ types of cancer, including those without ...

A West Texas congressman's bill has gotten a bipartisan nod to move forward to potentially ensure multi-cancer early detection (MCED) tests are covered by Medicare. On Thursday, the U.S. House Ways ...

Researchers at the CU Anschutz Cancer Center have launched a clinical trial funded by the National Cancer Institute that will ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major medical society recommends the test for screening.

In this episode, we are joined by Dr. Tom Beer, Chief Medical Officer and Vice President, Multi-Cancer Early Detection at Exact Sciences, to discuss multi-cancer early detection (MCED) testing and how ...

Cancerguard by Exact Sciences is the first of its kind early detection blood test for multiple kinds of cancer. Exact Sciences is a diagnostic company focusing on early cancer detection. Cancerguard ...

GRAIL, Inc. GRAL announced the submission of the final module of its premarket approval application to the FDA for the ...

We have a real-world evidence registry called Falcon, where we're enrolling up to 25,000 individuals who receive annual Cancerguard testing over three years. Our modeling studies suggest that if you ...

Imagine a future where some cancers are caught before symptoms appear, before they spread, before lives are disrupted. That’s the potential of multi-cancer early detection (MCED), a transformative ...

The Government has set out how it intends to transform cancer detection and treatment in a new 10-year plan.

Grail has filed for Food and Drug Administration approval of its multi-cancer early detection test, the company said Thursday ...

A bipartisan bill to ensure Medicare covers multi-cancer early detection tests has advanced in the U.S. House. The bill would allow Medicare to cover FDA-approved MCED screenings, which can detect ...